Follow-Up After Surgical Treatment of Peri-implantitis
This trial is active, not recruiting.
|Treatment||3 years follow-up|
|Start date||July 2016|
|End date||July 2016|
|Trial size||100 participants|
|Trial identifier||NCT02860208, olivier2|
The objective of this prospective clinical study was to evaluate the 3-year outcomes of anti-infective surgical treatment of peri-implantitis when a regular supportive peri-implant therapy (SPIT) programme was followed.
all patients who received surgical treatment for peri-implantitis during a Randomized and Controlled Trial registered in ClinicalTrials.gov NCT NCT01857804
Treatment success (pocket closure, no bleeding on probing, bone loss ≤0.5 mm between 12 months and 36 months after surgical therapy)
time frame: 3 years
Male or female participants of any age.
Inclusion Criteria: - all patients who received surgical treatment for peri-implantitis for 3 years ago Exclusion Criteria:
|Official title||Follow-Up After Surgical Treatment of Peri-implantitis|
|Description||The patients enrolled in this prospective study all received surgical treatment for peri-implantitis at one of 2 treatment centres (specialist periodontal practice, Mölndal and Gothenburg, Public Dental Health Services, Region Västra Götaland, Sweden) and were enrolled between October 2010 and December 2013.). All were treated by experienced periodontists. Details of the peri-implantitis treatment protocol have been described in a previous publication reporting on the 12-month clinical and radiographic treatment outcomes (Carcuac et al. 2016), registered at ClinicalTrials.gov (NCT01857804) and approved by the Regional Ethical Committee, Gothenburg, Sweden (Dnr. 654-10).|
Call for more information